Cullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States. It engages in the development of CLN-978, a CD19xCD3 bispecific T cell engager for autoimmu...
Leadership
Nadim Ahmed M.S.
President, CEO & Director
Mary Kay Fenton CPA
Chief Financial Officer
Jeffrey Jones M.B.A., M.D., M.P.H.
Chief Medical Officer
Patrick A. Baeuerle Ph.D.Founder
Co-Founder, Chief Scientific Advisor & Chairman of Scientific Advisory Board
